Recent News

• 06.11.2025 - Paysign Accelerates Growth With Ahead-of-Schedule Transition of 123 Plasma Donation Centers
• 06.06.2025 - Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Affordability
• 06.05.2025 - Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition
• 05.29.2025 - Paysign, Inc. to Present at the MicroCap Rodeo Spring Conference
• 05.13.2025 - Cracking the Code on Copay: From Mitigation to Mastery
• 05.08.2025 - Paysign, Inc. Reports First Quarter 2025 Financial Results
• 04.22.2025 - Paysign to Host First Quarter 2025 Earnings Call
• 04.21.2025 - Paysign is a Sponsor at the 2025 International Plasma Protein Therapeutics Conference, Warsaw, Poland

Recent Filings

• 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 8-K Current report
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 8-K Current report
• 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]